AuntMinnie

Lawsuit

7 malpractice risks in radiology and how to mitigate them

Malpractice suits may be an unfortunate reality for radiologists, but although they are a threat, they may also present an opportunity to improve imaging protocols.

Featured

Lymphoma Scan

PET radiomics model identifies high-risk lymphoma patients

Dexa Hip

Technicians have 'flexibility' during lumbar spine bone scans

Hybrid contrast-enhanced CT (with iodinated contrast bolus timed to maximize pulmonary arterial visualization) and F-18 DCFPyL PSMA-PET images. Contrast CT images (A, B) show an eccentric filling defect in the superior lingula segmental artery of the left lung upper lobe (red arrow). This is concordant with moderately intense PSMA radiotracer expression (black arrows on axial PET-only images, C, and on whole-body maximum intensity projection image, E). Fused PET and contrast-enhanced CT axial image (D) also confirm the lesion (red arrow). No other site of PSMA expressing metastasis is evident on whole-body imaging (E).

Rare finding detected on PSMA-PET: A nonprostatic lung tumor

September 25, 2023

Heart Attack Disease 3 D 400

American Indians, Alaskan Natives carry higher heart disease burden

September 25, 2023

Most cancers detected on breast screening MRI are invasive

September 25, 2023

Virtual Reality Surgical Doctor 400

Mixed reality tech doesn't distract most neurosurgery staff

September 22, 2023

Check out our Cases of the Week!

61-year-old woman with right lower quadrant pain for one week

A 61-year-old woman with a past surgical history of cholecystectomy and hernia repair with mesh presented to the ED with a complaint of right lower quadrant pain for one week. The patient reported feeling nauseous; she denied emesis, fever, chills, or changes in bowel movements.

19-year-old man with difficulty writing

57-year-old man with chest pain

Lymphoma Scan

PET radiomics model identifies high-risk lymphoma patients

Technicians have 'flexibility' during lumbar spine bone scans

Rare finding detected on PSMA-PET: A nonprostatic lung tumor

Most cancers detected on breast screening MRI are invasive

Pulmonary Embolism Illustration 400

Aidoc touts research at Pulmonary Embolism Symposium

Mixed reality tech doesn't distract most neurosurgery staff

Bracco inks agreement with Subtle Medical

AI-boosted opportunistic LDCT helps evaluate bone mineral density

Mri Brain Head Social

Researcher receives grant to study brain imaging data

Humana to cover Insightec's focused ultrasound treatment

Aidoc touts research at Pulmonary Embolism Symposium

Agfa to showcase its technology at RSNA

Pulmonary Embolism Illustration 400

Aidoc touts research at Pulmonary Embolism Symposium

Aidoc is highlighting research that demonstrates the company's technology at the ninth annual Pulmonary Embolism Symposium.

Bracco inks agreement with Subtle Medical

AI-boosted opportunistic LDCT helps evaluate bone mineral density

More Artificial Intelligence

Researcher receives grant to study brain imaging data

Researchers recently received a grant from the NIH to study brain imaging data for statistical learning of Alzheimer's disease.

September 25, 2023

Mri Brain Head Social

Humana to cover Insightec's focused ultrasound treatment

Humana is now covering Insightec's focused ultrasound treatment for medication-refractory essential tremor.

September 25, 2023

Insurance Computer 400

Aidoc touts research at Pulmonary Embolism Symposium

Aidoc is highlighting research that demonstrates the company's technology at the ninth annual Pulmonary Embolism Symposium.

September 22, 2023

Pulmonary Embolism Illustration 400

Agfa to showcase its technology at RSNA

Agfa will showcase its portfolio of imaging technologies at the upcoming 2023 RSNA annual meeting in Chicago.

September 22, 2023

Agfa Rsna 2019 400

Does the PI-RADS update change prostate cancer treatment staging?

PI-RADS upgrade and downgrade rates from targeted MRI biopsy to radical prostatectomy haven't changed between PI-RADS version 2.0 and 2.1.

September 22, 2023

62-year-old patient with serum PSA level of 4.11 ng/mL. Prostate MRI shows lesion in left midanterior transition zone. Lesion (arrow) shows hypointensity on T2-weighted image (A), hyperintensity on high b-value DWI (B), hypointensity on ADC map (C), and focal early enhancement on dynamic contrast-enhanced image (D). Lesion was assessed as category 4 using PI-RADS version 2.1 MRI-targeted biopsy of lesion revealed prostate adenocarcinoma with ISUP grade group 2. At subsequent radical prostatectomy performed 6 months after biopsy, ISUP grade group was upgraded to 3. ISUP, International Society of Urogenital Pathology. Image courtesy of AJR.

POCUS shows success in cave rescues

Point-of-care ultrasound (POCUS) showed success in two rescue operations from caving accidents.

September 22, 2023

Is Pylarify better than Ga-68 PSMA-11 for prostate cancer imaging?

Subtle differences in how PSMA-PET radiotracers perform in patients before Pluvicto treatment may determine which become the future tracers of choice.

September 22, 2023

PSMA-PET imaging

Income level impacted countries' cardiac imaging rates post-COVID

A country's income level appears to have impacted the recovery of its cardiac imaging rates after declines during the COVID-19 pandemic, researchers have found.

September 22, 2023

Heart Hologram Virtual Social

Bracco inks agreement with Subtle Medical

Bracco Imaging is partnering with Subtle Medical to advance the use of contrast-enhanced MRI around the world.

September 21, 2023

Bracco2 Rsna 2018 400

MolecuLight touts research presented at Wound Week

MolecuLight will present six clinical posters and a hands-on workshop at the American Professional Wound Care Association's Wound Week.

September 21, 2023

Molecule Technology 400

RefleXion acquires radiopharmaceutical rights from 3B Pharmaceuticals

RefleXion Medical and and 3B Pharmaceuticals recently entered into a licensing agreement for RefleXion to develop a specific 3BP molecule.

September 21, 2023

Reflexion Astro 2019 400

Hologic, Bayer partner for international CEM delivery

Hologic and Bayer are partnering to deliver contrast-enhanced mammography (CEM) to countries across the European, Canadian, and Asia-Pacific regions.

September 21, 2023

Mammo Reading 400 (2)